Drugs · acquisition-cost intelligence
Lidocaine 3%
Lidocaine HCl 3%· ingredient lidocaineAmides· LIDOCAINE HYDROCHLORIDE 30 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.63612
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other lidocaine products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| Burn Relief | $0.02792 | −$0.60820 |
| ALCEMISTE | $0.05101 | −$0.58510 |
| Lidocaine Viscous | $0.07984 | −$0.55630 |
| Lidocaine | $0.09024 | −$0.54590 |
| lidocaine | $0.15755 | −$0.47860 |
| Cadira Compliant Blood Stat | $0.21848 | −$0.41760 |
| LIDOCAINE HCl | $0.24343 | −$0.39270 |
| Lidocaine | $0.35160 | −$0.28450 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.